Literature DB >> 15307110

Reversible posterior leukoencephalopathy syndrome complicating cytotoxic chemotherapy for hematologic malignancies.

C S Tam1, J Galanos, J F Seymour, A G Pitman, R J Stark, H M Prince.   

Abstract

Reversible posterior leukoencephalopathy syndrome (RPLS) is an uncommon but distinctive clinicoradiological entity comprising of headache, seizures, visual disturbance, and altered mental function, in association with posterior cerebral white matter edema. With appropriate management, RPLS is reversible in the majority of cases. Previous reported associations of RPLS include hypertension, eclampsia, renal failure, and use of immunosuppressive drugs; reports in the adult hematology setting are rare. We report two cases of adults undergoing treatment for hematological malignancies who developed RPLS, and we emphasize the importance of early recognition and institution of appropriate management in reducing the risk of development of permanent neurological disability. Copyright 2004 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15307110     DOI: 10.1002/ajh.20147

Source DB:  PubMed          Journal:  Am J Hematol        ISSN: 0361-8609            Impact factor:   10.047


  28 in total

1.  Reversible posterior leukoencephalopathy in a venomous snake (Bothrops asper) bite victim.

Authors:  Miguel E Delgado; Oscar H Del Brutto
Journal:  Am J Trop Med Hyg       Date:  2012-03       Impact factor: 2.345

Review 2.  Neurologic complications of antitumor antibody therapies.

Authors:  Teri N Kreisl
Journal:  Curr Neurol Neurosci Rep       Date:  2008-05       Impact factor: 5.081

Review 3.  Reversible posterior leukoencephalopathy syndrome in cancer.

Authors:  Christopher Vaughn; Louann Zhang; David Schiff
Journal:  Curr Oncol Rep       Date:  2008-01       Impact factor: 5.075

4.  Posterior reversible encephalopathy syndrome in cancer patients: a single institution retrospective study.

Authors:  Carlos Kamiya-Matsuoka; Asif M Paker; Linda Chi; Ayda Youssef; Sudhakar Tummala; Monica E Loghin
Journal:  J Neurooncol       Date:  2016-02-22       Impact factor: 4.130

5.  Primary brain tumors and posterior reversible encephalopathy syndrome.

Authors:  Carlos Kamiya-Matsuoka; David Cachia; Adriana Olar; Terri S Armstrong; Mark R Gilbert
Journal:  Neurooncol Pract       Date:  2014-09-14

6.  Posterior reversible encephalopathy syndrome postautologous peripheral stem cell transplantation for multiple myeloma.

Authors:  Shahriar Raj Zaman
Journal:  BMJ Case Rep       Date:  2012-07-19

7.  Reversible posterior leukoencephalopathy syndrome induced by bevacizumab plus chemotherapy in colorectal cancer.

Authors:  Wei Wang; Li-Rong Zhao; Xiu-Qiang Lin; Fen Feng
Journal:  World J Gastroenterol       Date:  2014-06-07       Impact factor: 5.742

Review 8.  Rheumatologic diseases and posterior reversible encephalopathy syndrome: two case reports and review of the literature.

Authors:  Anmol Dhillon; Celso Velazquez; Chokkalingam Siva
Journal:  Rheumatol Int       Date:  2012-07-24       Impact factor: 2.631

9.  Reversible Posterior Leukoencephalopathy Syndrome Due to Carboplatin and Paclitaxel Therapy.

Authors:  Melek Kandemir; Belgin Küçükkaya; Muzaffer Savaş Tepe; Zehra Betül Yalçıner; Nedret Taflan Salepçi
Journal:  Balkan Med J       Date:  2015-10-01       Impact factor: 2.021

10.  Lysergic acid amide-induced posterior reversible encephalopathy syndrome with status epilepticus.

Authors:  Stephane Legriel; Fabrice Bruneel; Odile Spreux-Varoquaux; Aurelie Birenbaum; Marie Laure Chadenat; François Mignon; Nathalie Abbosh; Matthieu Henry-Lagarrigue; Laure Revault D'Allonnes; Pierre Guezennec; Gilles Troche; Jean Pierre Bedos
Journal:  Neurocrit Care       Date:  2008       Impact factor: 3.210

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.